Spectre Capital Corp. (the ‘Company’ or ‘Spectre’) is providing an update, further to its news release of September 9, 2020, on its proposed acquisition of Hemptown Organics Corp. (‘Hemptown’) (the ‘Transaction’). The Transaction, once complete, is expected to result in the reverse takeover of Spectre (thereafter, referred to as the ‘Resulting Issuer’) and will constitute Spectre's Qualifying Transaction under Policy 2.4 ­ Capital Pool Companies of the Exchange (the ‘CPC Policy’). In connection with the Transaction, it is expected that Robert Shewchuk and Stephen Ross Gatensbury will resign as a directors of the Company, and Geoff Balderson will resign as President and secretary of the Company.